|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | A PhRMA survey concludes 63% of member companies expect to shift at least some of their R&D investment away from small molecules as a result of the new legislation called the Inflation Reduction Act (IRA). But a lot of this movement has been ongoing for almost 20 years. So what's the real scene, as the industry and government are at loggerheads? |
|
|
Navigating Grades And Sources Of Materials In Drug Manufacturing | By Allison Radwick, RPh, Ph.D., U.S. Pharmacopeia | From raw materials to finished dosage forms, understanding material quality is essential in drug manufacturing. This article examines how material grades and sources guide selection for optimal safety and functionality. |
|
|
|
Four Reasons For The Rise In Blister Packaging | Article | By Yves Massicotte, Ropack Pharma Solutions | Examine the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth. |
|
|
|
|
|
KinetiSol Technology: Scale Up Approach | Webinar | AustinPx | Process parameter and quality attribute relationships, including those for typical pre and post KinetiSol unit operations, will be explored in the context of real-world examples. |
|
|
|
Controlled Substances | Cambrex | Cambrex holds U.S. Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances. |
|
|
High Potency Manufacturing Brochure | AbbVie | AbbVie Contract Manufacturing offers potent capabilities for drug products and APIs covering development phases to commercial production. We are among few companies with potent-capable facilities in North America and Europe. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
